Catherine Poole of the Melanoma International Foundation just announced that the Merck MK3475 (anti-PD1) Expanded Access Program just opened at the Angeles Clinic and Steven O'Day's Hollywood Clinic. Hooray!!
She also said that Amplimmune is accruing patients for their anti-PD1 trial. See NCT02013804- PD1. No prior PD1, but other therapies prior ok
Re: First expanded access anti-PD1!!
DZnDef - (4/4/2014 - 9:12pm)Does anyone have a link they could share that provides information on anti-PD1? I've seen it mentioned with lots of excitement but I don't know what it is or how it's supposed to work. Does it have nasty side-effects? Sorry, I'm a newbie. Just diagnosed Stage IV a couple of weeks ago. Thanks for the info.
Maggie
Maggie - Stage IV (lung mets unknown primary) since July 2012. Brain mets September 2016.Taf/Mek, gamma knife, Keytruda resulting in clean brain scan and tiny remnants in lung as of July 2017
Re: First expanded access anti-PD1!!
Anonymous - (4/5/2014 - 7:56am)Re: First expanded access anti-PD1!!
Anonymous - (4/5/2014 - 12:36pm)Under EAP for MK3475, does anyone know if Merck pays for doctor visits, lab tests, and the IV costs of getting Merck pd1. If not, do you know if insurance will cover associated costs for getting MKpd1 under the Merck EAP.
Re: First expanded access anti-PD1!!
DZnDef - (4/5/2014 - 5:59pm)Thank you, Anonymous!!
Maggie - Stage IV (lung mets unknown primary) since July 2012. Brain mets September 2016.Taf/Mek, gamma knife, Keytruda resulting in clean brain scan and tiny remnants in lung as of July 2017
Re: First expanded access anti-PD1!!
Anonymous - (4/6/2014 - 5:13am)I don't understand how this is seen as a breakthrough drug when we have no data on long term survival. Can anyone advise?